Leerink Partners Maintains a Buy Rating on Agilent (A)

Leerink Partners analyst Puneet Souda maintained a Buy rating on Agilent (AResearch Report) on January 7 and set a price target of $175.00. The company’s shares closed last Wednesday at $140.43.

According to, Souda ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -3.6% and a 37.3% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience.

Currently, the analyst consensus on Agilent is a Strong Buy with an average price target of $179.00.

See the top stocks recommended by analysts >>

Based on Agilent’s latest earnings release for the quarter ending October 31, the company reported a quarterly revenue of $1.66 billion and net profit of $442 million. In comparison, last year the company earned revenue of $1.48 billion and had a net profit of $222 million.

Based on the recent corporate insider activity of 103 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of A in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Agilent Technologies, Inc. is an analytical instrumentation development and manufacturing company. The company provides instruments, software, services, consumables, and expertise to address the full range of scientific and laboratory management needs.

Read More on A:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More